SPC Financial Inc. grew its holdings in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 231.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,786 shares of the financial services provider’s stock after buying an additional 4,741 shares during the quarter. SPC Financial Inc.’s holdings in iShares NASDAQ Biotechnology Index were worth $725,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. First Trust Advisors LP grew its stake in iShares NASDAQ Biotechnology Index by 0.5% in the second quarter. First Trust Advisors LP now owns 3,426 shares of the financial services provider’s stock worth $1,062,000 after purchasing an additional 18 shares in the last quarter. Security National Bank of Sioux City Iowa IA grew its stake in iShares NASDAQ Biotechnology Index by 0.9% in the second quarter. Security National Bank of Sioux City Iowa IA now owns 2,981 shares of the financial services provider’s stock worth $925,000 after purchasing an additional 27 shares in the last quarter. Parametric Portfolio Associates LLC grew its stake in iShares NASDAQ Biotechnology Index by 8.7% in the second quarter. Parametric Portfolio Associates LLC now owns 988 shares of the financial services provider’s stock worth $306,000 after purchasing an additional 79 shares in the last quarter. Eaton Vance Management grew its stake in iShares NASDAQ Biotechnology Index by 5.1% in the second quarter. Eaton Vance Management now owns 3,105 shares of the financial services provider’s stock worth $963,000 after purchasing an additional 151 shares in the last quarter. Finally, Bank Hapoalim BM grew its stake in iShares NASDAQ Biotechnology Index by 2.5% in the third quarter. Bank Hapoalim BM now owns 6,819 shares of the financial services provider’s stock worth $2,275,000 after purchasing an additional 169 shares in the last quarter. 21.23% of the stock is currently owned by hedge funds and other institutional investors.

iShares NASDAQ Biotechnology Index (IBB) traded down $1.08 during trading on Tuesday, reaching $110.90. The company’s stock had a trading volume of 1,872,741 shares, compared to its average volume of 2,761,855. The stock has a market capitalization of $10,270.00, a price-to-earnings ratio of 3.66 and a beta of 1.38. iShares NASDAQ Biotechnology Index has a one year low of $88.96 and a one year high of $114.17.

The business also recently announced a quarterly dividend, which was paid on Thursday, December 28th. Shareholders of record on Friday, December 22nd were issued a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, December 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.45%. This is a positive change from iShares NASDAQ Biotechnology Index’s previous quarterly dividend of $0.04. iShares NASDAQ Biotechnology Index’s dividend payout ratio is currently 2.38%.

COPYRIGHT VIOLATION NOTICE: This piece was published by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/spc-financial-inc-has-725000-stake-in-ishares-nasdaq-biotechnology-index-ibb/1809442.html.

iShares NASDAQ Biotechnology Index Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.